The effects of dithiaden on nitric oxide production by RAW 264.7 cells

Interdisciplinary Toxicology

Volumn 1, Issue 3-4, 2008, Pages 214-217

  Králová, Jana ^a   Pekarová, Michaela ^a   Drábiková, Katarina ^b   Janèinová, Viera ^b   Nosál, Radomir ^b   Èiž, Milan ^a   Lojek, Antonin ^a  

^a INSTITUTE OF BIOPHYSICS   (Czech Republic)

^b INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

Author keywords

dithiaden; inducible nitric oxide synthase; lipopolysaccharide; nitric oxide; nitrites; RAW 264.7 cells

Indexed keywords

EID: 77349110942     PISSN: 13376853     EISSN: 13379569     Source Type: Journal    
DOI: 10.2478/v10102-010-0044-9     Document Type: Article

References (16)

1. Bakker RA, Schoonus SB, Smit MJ, Timmerman H, Leurs R (2001) Histamine H(1)-receptor activation of nuclear factor-kappa B.: roles for G beta gamma-and G alpha(q/11)-subunits in constitutive and agonist-mediated signaling. Mol Pharmacol 60: 1133-1142.
2. De Vos C (1999) H1-receptor antagonists: effects on leukocytes, myth or reality? Clin Exp Allergy 29 Suppl 3: 60-63.
3. Feelisch M, Kelm M (1991) Biotransformation of organic nitrates to nitric oxide by vascular smooth muscle and endothelial cells. Biochem Biophys Res Commun 180: 286-293.
4. Church MK (2001) H(1)-antihistamines and inflammation. Clin Exp Allergy 31: 1341-1343.
5. Jancinova V, Drabikova K, Nosal R, Holomanova D (2006) Extra-and intracellular formation of reactive oxygen species by human neutrophils in the presence of pheniramine, chlorpheniramine and brompheniramine. Neuro Endocrinol Lett 27 Suppl 2: 141-143.
6. Kralova J, Ciz M, Nosal R, Drabikova K, Lojek A (2006) Effect of H(1)-antihistamines on the oxidative burst of rat phagocytes. Inflamm Res 55 Suppl 1: S15-16.
7. Kralova J, Nosal R, Drabikova K, Jancinova V, Denev P, Moravcova A, et al. (2008) Comparative investigations of the influence of H1-antihistamines on the generation of reactive oxygen species by phagocytes. Inflamm Res 57 Suppl 1: S49-50.
8. Lawrence T, Willoughby DA, Gilroy DW (2002) Anti-inflammatory lipid mediators and insights into the resolution of inflammation. Nat Rev Immunol 2: 787-795.
9. Lullmann H, Plosch H, Ziegler A (1980) Ca replacement by cationic amphiphilic drugs from lipid monolayers. Biochem Pharmacol 29: 2969-2974.
10. McInnes IB, Leung BP, Field M, Wei XQ, Huang FP, Sturrock RD, Kinninmonth A, Weidner J, Mumford R, Liew FY (1996) Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients. J Exp Med 184: 1519-1524.
11. Migliorini P, Corradin G, Corradin SB (1991). Macrophage NO2-production as a sensitive and rapid assay for the quantitation of murine IFN-gamma. J Immunol Methods 139: 107-114. Moncada S, Higgs A (1993) The L-arginine-nitric oxide pathway. N Engl J Med 329: 2002-2012.
12. Nosal R, Drabikova K, Ciz M, Lojek A, Danihelova E (2002) Effect of H1-antagonist Dithiaden on human PMN-leukocyte aggregation and chemiluminescence is stimulus-dependent. Inflamm Res 51: 557-562.
13. Nosal R, Drabikova K, Jancinova V, Petrikova M, Fabryova V (2005) Antiplatelet and antiphagocyte activity of H1-antihistamines. Inflamm Res 54 Suppl 1: S19-20.
14. Nosal R, Drabikova K, Jancinova V, Macickova T, Pecivova J, Holomanova D (2006) On the pharmacology and toxicology of neutrophils. Neuro Endocrinol Lett 27 Suppl 2: 148-151.
15. Palmer RM, Ferrige AG, Moncada S (1987). Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524-526.
16. Stuehr DJ, Marletta MA (1985) Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc Natl Acad Sci USA 82: 7738-7742.